Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Endocrinology

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.2009-0377PMID 19443570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Activation of Insulin Receptor Substrates 1 and 2 by Insulin-Like Growth Factor-Activated Insulin Receptors

  2007influential reference
• The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer.

  2007cited by this paper
• Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCε and PKCδ, in adult cardiac muscle cells

  2007cited by this paper
• Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCepsilon and PKCdelta, in adult cardiac muscle cells.

  2007cited by this paper
• Protein Synthesis and Oncogenesis Meet Again

  2006cited by this paper
• MAPK signal specificity: the right place at the right time.

  2006cited by this paper
• Specific protein kinase C isoforms as transducers and modulators of insulin signaling.

  2006cited by this paper
• Signal transduction. Protein synthesis and oncogenesis meet again.

  2006cited by this paper
• Ser/Thr Phosphorylation of IRS Proteins: A Molecular Basis for Insulin Resistance

  2005cited by this paper
• Protein kinase B/Akt at a glance

  2005cited by this paper
• Shp2 Is Required for Protein Kinase C-dependent Phosphorylation of Serine 307 in Insulin Receptor Substrate-1*

  2005cited by this paper
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

  2005cited by this paper
• Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.

  2005cited by this paper
• Growing roles for the mTOR pathway.

  2005cited by this paper
• Distinct Signaling Events Downstream of mTOR Cooperate To Mediate the Effects of Amino Acids and Insulin on Initiation Factor 4E-Binding Proteins

  2005cited by this paper
• Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity

  2004influential reference
• mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E

  2004cited by this paper
• IGF‐II Binding to Insulin Receptor Isoform A Induces a Partially Different Gene Expression Profile from Insulin Binding

  2004cited by this paper
• Protein Kinase Cζ (PKCζ) : Activation Mechanisms and Cellular Functions

  2003cited by this paper
• Differential Gene Expression Induced by Insulin and Insulin-like Growth Factor-II through the Insulin Receptor Isoform A*

  2003cited by this paper
• Bi-directional Regulation of Brown Fat Adipogenesis by the Insulin Receptor*

  2003cited by this paper
• Molecular crosstalk between p70S6k and MAPK cell signaling pathways.

  2002cited by this paper
• Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.

  2002cited by this paper
• Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action*

  2002cited by this paper
• c-Raf/MEK/ERK Pathway Controls Protein Kinase C-mediated p70S6K Activation in Adult Cardiac Muscle Cells*

  2002cited by this paper
• In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A

  2002cited by this paper
• Insulin/Insulin-like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved*

  2002cited by this paper
• Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.

  2002cited by this paper
• Role of S6 phosphorylation and S6 kinase in cell growth.

  2001cited by this paper
• A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1

  2001cited by this paper
• p70 S6 Kinase Is Regulated by Protein Kinase Cζ and Participates in a Phosphoinositide 3-Kinase-Regulated Signalling Complex

  1999cited by this paper
• Protein Kinase Cζ Is a Negative Regulator of Protein Kinase B Activity*

  1999cited by this paper
• Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells

  1999influential reference
• Regulation of protein kinase C ζ by PI 3-kinase and PDK-1

  1998cited by this paper
• Amino Acid Sufficiency and mTOR Regulate p70 S6 Kinase and eIF-4E BP1 through a Common Effector Mechanism*

  1998cited by this paper
• RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1.

  1998cited by this paper
• Regulation of the p70 S6 Kinase by Phosphorylation in Vivo

  1998cited by this paper
• p70 S6 kinase is activated by sodium arsenite in adult rat cardiomyocytes: roles for phosphatidylinositol 3-kinase and p38 MAP kinase.

  1997cited by this paper
• Dual requirement for a newly identified phosphorylation site in p70s6k

  1997cited by this paper
• The modular phosphorylation and activation of p70s6k

  1997cited by this paper
• Insulin-like growth factor II stimulates cell proliferation through the insulin receptor.

  1997cited by this paper
• Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.

  1997cited by this paper
• 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase.

  1997cited by this paper
• The principal target of rapamycin‐induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain.

  1995cited by this paper
• Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts

  1994cited by this paper
• Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun

  1994cited by this paper
• Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation

  1994influential reference
• Ligand-binding properties of the two isoforms of the human insulin receptor.

  1993cited by this paper
• Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells.

  1993cited by this paper
• The insulin-like growth factor family of ligands, receptors, and binding proteins

  1992influential reference
• An array of insulin-activated, proline-directed serine/threonine protein kinases phosphorylate the p70 S6 kinase.

  1992cited by this paper
• Functionally distinct insulin receptors generated by tissue‐specific alternative splicing.

  1990cited by this paper
• Alternative splicing of human insulin receptor messenger RNA.

  1989cited by this paper

• Microenvironmental determinants of cancer progression during obesity: emerging evidence and novel perspectives

  2025cites this paper
• Insulin receptor alternative splicing in breast and prostate cancer

  2024cites this paper
• Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies

  2024cites this paper
• Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance

  2023cites this paper
• Comparative proteomic analysis of insulin receptor isoform A and B signaling.

  2022cites this paper
• IGF-I induces upregulation of DDR1 collagen receptor in breast IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway. pathway.

  2022cites this paper
• Subventricular zone adult mouse neural stem cells require insulin receptor for self-renewal

  2022cites this paper
• Insulin-Like Growth Factor 2 As a Possible Neuroprotective Agent and Memory Enhancer—Its Comparative Expression, Processing and Signaling in Mammalian CNS

  2021cites this paper
• Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells

  2021cites this paper
• The IGF-II–Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives

  2020cites this paper
• The relation between of insulin like growth factor II and endometrial carcinoma

  2020cites this paper
• Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma

  2020influential citation
• Hormone Effects on Tumors

  2020cites this paper
• Isoform- and Paralog-Switching in IR-Signaling: When Diabetes Opens the Gates to Cancer

  2020cites this paper
• Subventricular zone adult mouse neural stem cells and human glioblastoma stem cells require insulin receptor for self-renewal

  2020cites this paper
• ANALOGHI DELL’INSULINA E CANCRO

  2019cites this paper
• The Neglected Insulin: IGF-II, a Metabolic Regulator with Implications for Diabetes, Obesity, and Cancer

  2019cites this paper
• Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation

  2019cites this paper
• Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection.

  2019cites this paper
• Converting Insulin-like Growth Factors 1 and 2 into High-Affinity Ligands for Insulin Receptor Isoform A by the Introduction of an Evolutionarily Divergent Mutation.

  2018cites this paper
• Chemical modifications of insulin: Finding a compromise between stability and pharmaceutical performance

  2018cites this paper
• Insulin receptor in the brain: Mechanisms of activation and the role in the CNS pathology and treatment

  2018cites this paper
• Long-acting insulin analogs and cancer.

  2018cites this paper
• Proinsulin Promotes Self-Renewal of a Hematopoietic Progenitor Cell Line In Vitro

  2017cites this paper
• A Mechanistic Investigation of Insulin Receptor Substrate 2 Function in Breast Cancer Progression

  2017cites this paper
• Insulin Receptor Isoforms in Physiology and Disease: An Updated View

  2017cites this paper
• Insulin‐like growth factor axis targeting in cancer and tumour angiogenesis – the missing link

  2017influential citation
• Papel de la lipoatrofia marrón, las isoformas del receptor de insulina y el receptor de IGF-I en la aterosclerosis experimental y humana

  2017cites this paper
• IGF system targeted therapy: Therapeutic opportunities for ovarian cancer.

  2017cites this paper
• Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival

  2016cites this paper
• Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis

  2016cites this paper
• Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain*

  2016cites this paper
• Type I insulin-like growth factor receptor signaling in hematological malignancies

  2016cites this paper
• Elucidating the Activation Mechanism of the Insulin-Family Proteins with Molecular Dynamics Simulations

  2016cites this paper
• Novel method demonstrates differential ligand activation and phosphatase-mediated deactivation of insulin receptor tyrosine-specific phosphorylation.

  2016cites this paper
• Insulin receptor isoforms: an integrated view focused on gestational diabetes mellitus

  2016cites this paper
• Novel Aspects Concerning the Functional Cross-Talk between the Insulin/IGF-I System and Estrogen Signaling in Cancer Cells

  2015cites this paper
• IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway

  2015cites this paper
• 1 INSULIN RECEPTOR ISOFORM A CONFERS A HIGHER PROLIFERATIVE CAPABILITY TO PANCREATIC BETA CELLS ENABLING GLUCOSE AVAILABILITY AND IGF-I SIGNALLING

  2015cites this paper
• Ligand-Binding Affinity at the Insulin Receptor Isoform-A and Subsequent IR-A Tyrosine Phosphorylation Kinetics are Important Determinants of Mitogenic Biological Outcomes

  2015cites this paper
• Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses

  2015cites this paper
• Ligand-Mediated Endocytosis and Trafficking of the Insulin-Like Growth Factor Receptor I and Insulin Receptor Modulate Receptor Function

  2014cites this paper
• Insulin-like Growth Factor-II (IGF-II) and IGF-II Analogs with Enhanced Insulin Receptor-a Binding Affinity Promote Neural Stem Cell Expansion*

  2014cites this paper
• The Emerging Role of Insulin and Insulin-Like Growth Factor Signaling in Cancer Stem Cells

  2014cites this paper
• Targeting the insulin-like growth factor pathway in hepatocellular carcinoma.

  2014cites this paper
• Факторы, определяющие выживаемость клеток множественной миеломы человека in vitro

  2014influential citation
• Factors determining in vitro survival of human multiple myeloma cells

  2014cites this paper
• Insulin Receptor Signaling is Necessary for the Maintenance of Epithelial Phenotype in MCF10A Cells

  2013cites this paper
• Designing novel therapies against sarcomas in the era of personalized medicine and economic crisis.

  2013cites this paper
• Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive.

  2013cites this paper
• Inhibition of insulin receptor function by a human, allosteric monoclonal antibody

  2013influential citation
• Insulin-like growth factor physiology: what we have learned from human studies.

  2012cites this paper
• Obesity, Type 2 Diabetes and Cancer

  2012cites this paper
• Análise da proteína AKT/PKB em Tecidos de Hiperplasia Prostática Benigna tratados e não tratados com Insulina e IGF-I.

  2012cites this paper
• What we have Learned from Human Studies

  2012cites this paper
• Amino acids potentiate insulin signaling in CHO-K1 at high glucose conditions.

  2012cites this paper
• Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma.

  2012cites this paper
• Proinsulin binds with high affinity the insulin receptor isoform A and predominantly activates the mitogenic pathway.

  2012cites this paper
• Diverse functions of IGF/insulin signaling in malignant and noncancerous prostate cells: proliferation in cancer cells and differentiation in noncancerous cells.

  2012cites this paper
• IGF‐II Promotes Stemness of Neural Restricted Precursors

  2012cites this paper
• Insulin and Insulin-like Growth Factor II Differentially Regulate Endocytic Sorting and Stability of Insulin Receptor Isoform A*

  2012cites this paper
• Overlaps Between the Insulin and IGF-I Receptor and Cancer

  2012cites this paper
• Understanding the Mechanism of Insulin and Insulin-Like Growth Factor (IGF) Receptor Activation by IGF-II

  2011cites this paper
• Insulin receptor and cancer.

  2011influential citation
• Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid.

  2011cites this paper
• Malaguarnera : IR and cancer Studies linking insulin resistance , circulating insulin , and cancer

  2011cites this paper
• Endocrine-Related Cancer ( 2011 ) 18 R 125 – R 147 Insulin receptor and cancer

  2011influential citation
• The Insulin Receptor: A New Target for Cancer Therapy

  2011influential citation
• Molecular Basis of Signaling Specificity of Insulin and IGF Receptors: Neglected Corners and Recent Advances

  2011cites this paper
• Research resource: New and diverse substrates for the insulin receptor isoform A revealed by quantitative proteomics after stimulation with IGF-II or insulin.

  2011cites this paper
• Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling

  2010cites this paper
• Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir

  2010cites this paper
• Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir.

  2010cites this paper
• Insulin analogues and cancer risk: cause for concern or cause célèbre?

  2010cites this paper
• Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.

  2010cites this paper
• Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

  2009cites this paper
• Факторы, определяющие выживаемость клеток множественной миеломы человека in vitro

  year unknowncites this paper